Z6×ðÁú

¼¯ÍÅȺվ
  • ÌìµÀÒ½Ò©Öйú
  • ÌìµÀÒ½Ò©Ó¢¹ú
  • ÌìµÀÒ½Ò©²¨À¼
  • ÌìµÀÒ½Ò©Òâ´óÀû
  • ÌìµÀÒ½Ò©Î÷°àÑÀ
  • ÌìµÀÒ½Ò©µÂ¹ú
  • ÌìµÀÒ½Ò©ÃÀ¹ú
  • ÈüÍåÉúÎï
  • SPL
Z6×ðÁú¡¤¿­Ê±(Öйú)ÈËÉú¾ÍÊDz«£¡ Z6×ðÁú¡¤¿­Ê±(Öйú)ÈËÉú¾ÍÊDz«£¡

¸üרÐÄ£¬Ö»Îª¸üºÃµØ»¤ÓÓ¿µ½¡

ÎÒÃǽ«¶Ô»¼Õߵľì×¢ÌåÏÖÔÚÒ©ÎïÉú²úºÍÔËתµÄÈ«Àú³Ìϸ½Ú°Ñ¿ØÖÐ
Heparin Sodium Injection
ͨÓÃÃû£º
¸ÎËØÄÆ×¢ÉäÒº
ÏúÊÛÊг ¡£º
ÃÀ¹ú
¹æ¸ñ£º
5,000 USP Heparin Units/mL,1 mL Multiple-Dose Vial 1,000 USP Heparin Units/mL,2 mL Single-Dose Vial
˳Ӧ֢£º
Heparin sodium injection is indicated for:

¡¤Prophylaxis and treatment of venous thrombosis and pulmonary embolism.

¡¤Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease.

¡¤Atrial fibrillation with embolization.

¡¤Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation).

¡¤Prevention of clotting in arterial and cardiac surgery.

¡¤Prophylaxis and treatment of peripheral arterial embolism.

¡¤Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿